Cancer Immunotherapy
Join us at facebook
  • General information
  • For clinicians
    • How to apply
  • Research Group
  • For patients
  • Support us
  • Bladder Cancer - current trial
  • Different forms of cancer
    • Bladder Cancer
    • Gastrointestinal
    • Liver cancer
    • Lung metastases of Kidney cancer
    • Lung Metastases
    • Melanoma
    • Mesothelioma
    • Nasopharynx
    • Prostate Cancer
    • Other Cancers
  • FAQs
  • Contact
  • Veterinary immunotherapy
  • Nederlandse website
  • Dieren met kanker (NL)
  • Links

Recurrent bladder carcinoma

Picture
Superficial bladder carcinoma is a frequently occurring disease. It is treated with surgery, named Transurethral Resection (TUR). After surgery these tumours often recur. Therefore after TUR, chemotherapeutics are often instilled in the bladder. We have tested IL-2 instillation in the bladder. Good therapeutic results were obtained.Presently we are trying to further improve this TUR-local-IL-2 therapy in patients with superficial bladder carcinoma.

Trial from 2011 to 2013

Picture
In 2011 - 2013 the Dept. Urology of VU University Medical Center, Amsterdam, the Netherlands organizes a multicenter phase II study for local IL-2 therapy, more info in Dutch.
The study will also be performed at the Academic Medical Center and the Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
For more information email to Dr J.J.L. Jacobs, [email protected]

References

Tubaro et al. (1995) Eur. Urol. 28, 297
W. Den Otter et al. (1998) J. Urol. 159, 1183
Grasso et al. (2001) J. Immunother. 24, 184
JJL Jacobs et al. The Open Cancer Immunology Journal 3 : 8-14 (2010).
D. Characiejus et al. Anticancer Research 31:699-703(2011).
Powered by Create your own unique website with customizable templates.